Computing Resources: Difference between revisions
Jump to navigation
Jump to search
(Initial table, no figures) |
(Imaging for Drug Screening) |
||
| Line 14: | Line 14: | ||
| Mass spectra || DESI || Leukemia Biology / Pathology || | | Mass spectra || DESI || Leukemia Biology / Pathology || | ||
|- | |- | ||
| Imaging || Drug Screening || Leukemia Biology || | | Imaging || Drug Screening || Leukemia Biology || || || 15 || 25 || | ||
|- | |- | ||
| Panel || Drug Screening || Leukemia Biology || | | Panel || Drug Screening || Leukemia Biology || | ||
Revision as of 17:11, 15 April 2024
| Type of Data | Project | Lab | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| MRD | Routine | Molecular Biology | |||||
| Exome | Precision Medicine | Epigenomics | |||||
| ctDNA | Circular Tumoral DNA | Molecular Biology | |||||
| Methylome | Precision Medicine | Epigenomics | |||||
| Mass spectra | DESI | Leukemia Biology / Pathology | |||||
| Imaging | Drug Screening | Leukemia Biology | 15 | 25 | |||
| Panel | Drug Screening | Leukemia Biology | |||||
| Methylome | Drug Screening | Leukemia Biology | |||||
| RNASeq | Drug Screening | Leukemia Biology |